AKTX (Akari Therapeutics PLC) Net Profit
Akari Therapeutics protects its market niche based on stringent FDA requirements and patent law. The company's net income clearly confirms this resilience, where the -0.03 mark characterizes this parameter. The development of the rare pathology therapy ecosystem via the drug Nomacopan is complemented by established precision logistics, which guarantee uninterrupted supplies and high business margins.
Analytical breakdowns and data insights for company Akari Therapeutics Plc (AKTX)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Akari Therapeutics|AKTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Akari Therapeutics PLC|AKTX - Company Total Debt|Debts to Book Capitalization Akari Therapeutics, Plc|AKTX - Company Long-Term Debt|Company Short-Term Indebtedness Akari Therapeutics|Immediate Liquidity akaritx.com
- net income and valuation multiples indicators:
Summary company analysis:Akari Therapeutics
This indicator captures the net financial result after deducting all operating expenses and taxes, allowing for the separation of real asset monetization from market speculation. For Akari Therapeutics (AKTX), which develops vital complement inhibitors, the company's aggregate profit trend on the GURU.Markets platform reflects the effectiveness of commercializing rare blood disease therapies and the resilience of the business model under strict margin controls.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|Nektar Therapeutics (NKTR) - Company Net Income|upstreambio.com (UPB) - Net Profit|ZBIO (Zenas Biopharma) - Net Profit|Net Profit Immunome Inc|Company Net Income Gossamer Corp (GOSS)|KALV (KalVista Corp) - Final Profit|Net Profit SEPN (Septerna Inc)|Net Financial Result pieris.com (PVLA)|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Net Income|ATXS: Profit After Payment of Taxes|ENGN (enGene Holdings Inc.) - Net Profit|RAPT: Final Profit|Net Profit JBIO|ACRS - Company Net Income|Company Net Income Kyverna KYTX|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|VTYX - Net Profit|Theratechnologies (THTX) - Company Net Income|Profit After Tax AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Net Profit|Company Net Income Agenus, Inc AGEN|Net Income CLYM (Climb Bio Inc)|Net Profit zurabio.com (ZURA)|aTyr Pharma - Net Income|Profit After Payment of Taxes ADAG (Adagene Inc)|Ikena Oncology, Inc. - Net Profit|Net Financial Result Shattuck Labs, Inc. STTK|EQ: Net Profit|Net Income Connect Biopharma Holdings Limited|Company Net Income Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Net Profit IFRX|Net Profit X4 Pharmaceuticals, Inc (XFOR)|Company Net Income Adicet Bio, Inc. ACET|Net Profit Celularity Inc CELU|INMB: Net Income|Barinthus Biotherapeutics PLC - Profit After Payment of Taxes|KZR (Kezar Life Sciences, Inc) - Net Income|Company Profit SABS|Company Net Income Enlivex Therapeutics Ltd|Q32 Bio Corp - Profit After Tax|Net Profit GOVX|EDSA (Edesa Biotech Inc) - Final Profit|Net Profit IBIO (iBio Corp)|Net Profit Carisma Therapeutics Inc CARM|XTLB - Company Net Income|Final Profit BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Company Net Income|Net Income Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Net Profit|Net Profit Aditxt Corp|Net Income GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Final Profit|Net Profit HIND (Vyome Holdings)|Net Financial Result Revelation Biosciences Inc (REVB)|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|Net Income ALLK|Net Profit HOOKIPA|Company Net Income IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Company Profit|Net Profit OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Company Net Income|Third Harmonic Bio, Inc. - Net Profit